Focused Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,114
| Closed | -$90.3K | – | 492 |
|
|
2023
Q4 | $90.3K | Buy |
1,114
+4
| +0.4% | +$311 | 0.01% | 214 |
|
|
2023
Q3 | $83.2K | Buy |
1,110
+5
| +0.5% | +$385 | 0.01% | 223 |
|
|
2023
Q2 | $85.2K | Sell |
1,105
-295
| -21% | -$23.5K | 0.02% | 228 |
|
|
2023
Q1 | $116K | Sell |
1,400
-121
| -8% | -$10K | 0.02% | 187 |
|
|
2022
Q4 | $131K | Buy |
1,521
+4
| +0.3% | +$317 | 0.03% | 165 |
|
|
2022
Q3 | $94K | Buy |
1,517
+5
| +0.3% | +$315 | 0.02% | 188 |
|
|
2022
Q2 | $93K | Sell |
1,512
-12
| -0.8% | -$743 | 0.02% | 195 |
|
|
2022
Q1 | $91K | Buy |
1,524
+6
| +0.4% | +$384 | 0.01% | 219 |
|
|
2021
Q4 | $110K | Sell |
1,518
-88
| -5% | -$6.06K | 0.02% | 273 |
|
|
2021
Q3 | $112K | Buy |
1,606
+23
| +1% | +$1.62K | 0.02% | 272 |
|
|
2021
Q2 | $109K | Buy |
1,583
+6
| +0.4% | +$401 | 0.02% | 274 |
|
|
2021
Q1 | $102K | Sell |
1,577
-96
| -6% | -$6.19K | 0.02% | 277 |
|
|
2020
Q4 | $97K | Buy |
1,673
+342
| +26% | +$20.6K | 0.02% | 272 |
|
|
2020
Q3 | $84K | Sell |
1,331
-113
| -8% | -$7.84K | 0.02% | 266 |
|
|
2020
Q2 | $111K | Buy |
1,444
+454
| +46% | +$34.8K | 0.03% | 211 |
|
|
2020
Q1 | $74K | Sell |
990
-371
| -27% | -$25.6K | 0.02% | 244 |
|
|
2019
Q4 | $88K | Sell |
1,361
-349
| -20% | -$22.7K | 0.02% | 263 |
|
|
2019
Q3 | $108K | Sell |
1,710
-46
| -3% | -$3.01K | 0.03% | 222 |
|
|
2019
Q2 | $118K | Sell |
1,756
-2,258
| -56% | -$149K | 0.03% | 217 |
|
|
2019
Q1 | $261K | Sell |
4,014
-6,555
| -62% | -$436K | 0.08% | 119 |
|
|
2018
Q4 | $661K | Sell |
10,569
-6,025
| -36% | -$421K | 0.23% | 69 |
|
|
2018
Q3 | $1.28M | Sell |
16,594
-8,107
| -33% | -$612K | 0.44% | 45 |
|
|
2018
Q2 | $1.75M | Buy |
24,701
+670
| +3% | +$47.3K | 0.61% | 32 |
|
|
2018
Q1 | $1.81M | Buy |
24,031
+1,019
| +4% | +$81K | 0.58% | 35 |
|
|
2017
Q4 | $1.65M | Sell |
23,012
-1,956
| -8% | -$149K | 0.53% | 34 |
|
|
2017
Q3 | $2.02M | Buy |
24,968
+3,501
| +16% | +$268K | 0.67% | 28 |
|
|
2017
Q2 | $1.52M | Buy |
21,467
+72
| +0.3% | +$4.79K | 0.57% | 32 |
|
|
2017
Q1 | $1.45M | Sell |
21,395
-696
| -3% | -$48.9K | 0.57% | 32 |
|
|
2016
Q4 | $1.58M | Buy |
22,091
+4,296
| +24% | +$319K | 0.67% | 28 |
|
|
2016
Q3 | $1.41M | Sell |
17,795
-1,327
| -7% | -$108K | 0.62% | 29 |
|
|
2016
Q2 | $1.59M | Buy |
19,122
+5
| +0% | +$444 | 0.73% | 28 |
|
|
2016
Q1 | $1.76M | Buy |
19,117
+3,970
| +26% | +$358K | 0.96% | 25 |
|
|
2015
Q4 | $1.53M | Buy |
15,147
+2,547
| +20% | +$265K | 0.88% | 26 |
|
|
2015
Q3 | $1.24M | Buy |
12,600
+4,905
| +64% | +$545K | 0.79% | 30 |
|
|
2015
Q2 | $901K | Buy |
7,695
+233
| +3% | +$25.5K | 0.56% | 39 |
|
|
2015
Q1 | $732K | Sell |
7,462
-215
| -3% | -$21.8K | 0.45% | 42 |
|
|
2014
Q4 | $724K | Buy |
7,677
+5,157
| +205% | +$533K | 0.51% | 41 |
|
|
2014
Q3 | $268K | Buy |
2,520
+2,270
| +908% | +$222K | 0.21% | 82 |
|
|
2014
Q2 | $21K | Buy |
+250
| New | +$19.5K | 0.02% | 301 |
|
Other funds holding GILD
Focused Wealth Management's GILD Position: Q1 2024 in Review
Focused Wealth Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 1,114 shares — an estimated $90.3K sold.
Focused Wealth Management first reported a position in GILD in Q2 2014 and held it in 39 quarters. The position peaked at $2.02M in Q3 2017. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Focused Wealth Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Focused Wealth Management sold 1,114 Gilead Sciences shares in Q1 2024, an estimated $90.3K.
- Focused Wealth Management first reported a position in Gilead Sciences in Q2 2014 and held it in 39 quarters.
- Focused Wealth Management's Gilead Sciences position peaked at $2.02M in Q3 2017.
- 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.